Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

News & Insights

Kiran Sheffrin Featured as a 2024 Tax “Rising Star” by Law360

July 22, 2024

On July 17, 2024, Cravath of counsel Kiran Sheffrin was featured as part of Law360’s 2024 “Rising Stars” series as one of the top tax attorneys in the nation under the age of 40. The related profile highlights Kiran’s representation of clients such as Anheuser‑Busch InBev and Valvoline on multibillion‑dollar deals, as well as Mylan in its $50 billion combination with Upjohn to create global pharmaceutical company Viatris.

Kiran noted that she was drawn to tax law because of its dynamism and critical role in the business world. “Although I work on a lot of deals,” she told Law360, “my attitude is that I want to learn something new from every deal and become a better adviser to my clients.” Asked to contemplate how tax law will evolve in the next decade, Kiran reflected on potential changes to tax regimes around the world and the shifting role of tax lawyers and advisors, adding that “clients have to rely on us to get them through these uncertain and ever‑changing times and not only help them analyze the technical issues but also be a sounding board when there is no clear answer or guidance for them to follow.”

Please click here to read the profile.

Related Practices & Industries

  • Tax
  • Consumer Products and Services
  • Industrials and Chemicals
  • Healthcare and Life Sciences

Related News & Insights

Deals & Cases

August 01, 2022

Valvoline’s $2.65 Billion Sale of its Global Products Business to Aramco

On August 1, 2022, Valvoline Inc., a global leader in vehicle care, announced it has reached a definitive agreement with Aramco for the sale of Valvoline’s Global Products business to Aramco for $2.65 billion in cash. Cravath is representing Valvoline in connection with the transaction.

Deals & Cases

July 29, 2019

Mylan’s $50 Billion Combination with Upjohn, a Division of Pfizer

On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.